Publicaciones (25) Publicaciones de JUANA MARÍA ESTENOZ ALFARO

2018

  1. 18 F-FDG PET/CT in a cardiac metastasis in a patient with history of malignant neuroectodermal tumour of the chest wall: Case report and review of the literature

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 2, pp. 110-113

2016

  1. Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case

    Case Reports in Oncology, Vol. 9, Núm. 1, pp. 255-261

2003

  1. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4

    Lung Cancer, Vol. 40, Núm. 3, pp. 289-294

  2. Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis

    American Journal of Medicine, Vol. 115, Núm. 5, pp. 365-370

2002

  1. Tumor cytosol carcinoembryonic antigen as prognostic parameter in non-small cell lung cancer

    Tumori, Vol. 88, Núm. 2, pp. 142-146

2000

  1. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: Effect of treatment with folic acid

    Clinical Transplantation, Vol. 14, Núm. 2, pp. 110-114

1999

  1. Factores de riesgo y densidad mineral osea en mujeres en tratamiento prolongado con levotiroxina

    Medicina Clinica, Vol. 112, Núm. 3, pp. 85-89

  2. La hiperhomocisteinemia es frecuente en pacientes con enfermedad coronaria. Estudio de 202 enfermos

    Medicina Clinica, Vol. 113, Núm. 11, pp. 407-410

1996

  1. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and ca 19-9 assay in pleural fluid: A study of 207 patients

    Cancer, Vol. 78, Núm. 4, pp. 736-740

  2. Interferon-γ in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis

    European Respiratory Journal, Vol. 9, Núm. 12, pp. 2635-2639

  3. Valores de referencia para el diagnóstico de la anemia en el anciano

    Revista Clinica Espanola, Vol. 196, Núm. 5, pp. 289-292

1995

  1. Determination of tissue polypeptide-specific antigen in pleural fluid and serum from patients with pleural effusion

    International Journal of Biological Markers, Vol. 10, Núm. 3, pp. 161-165

  2. Study of serum tumor markers CEA, CA 15.3 and CA 27.29 as diagnostic parameters in patients with breast carcinoma

    International Journal of Biological Markers, Vol. 10, Núm. 1, pp. 24-29

1992

  1. Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies

    Medicina clínica, Vol. 99, Núm. 1, pp. 1-5

1991

  1. Erythropoietin and improvement in the erythropoiesis of chronic hemodialysis patients treated with desferrioxamine [9]

    Clinical Nephrology

  2. Estabilidad del ácido fólico y vitamina B12 en NPT.

    Nutricion Hospitalaria, Vol. 6, Núm. 4, pp. 249-253

1989

  1. Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: A prospective randomized trial

    Transplantation Proceedings, Vol. 21, Núm. 1 II, pp. 1537-1539

1987

  1. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome

    Journal of Hepatology, Vol. 5, Núm. 2, pp. 167-173

  2. Improvement of anaemia with desferrioxamine in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 2, Núm. 4, pp. 243-247

1986

  1. Urinary excretion of enzymes in cirrhotics with renal failure

    Journal of Hepatology, Vol. 3, Núm. 1, pp. 123-130